|
Group
No. |
Group
Title |
Case
No. |
Brief
Title |
| |
|
|
|
|
1.
|
PATENTABILITY
|
|
|
| |
|
1.
|
Computer
Programme |
| |
|
2.
|
Computer
Graphic Displays |
| |
|
3.
|
Machine
Programme |
| |
|
4.
|
Micoorganism
|
| |
|
5.
|
Plant
Genetic Systems |
| |
|
6.
|
Validity
of Plant Patent |
|
2.
|
NOVELTY
|
|
|
| |
|
7.
|
Prior
Knowledge |
| |
|
8.
|
Prior
Art in Patenting |
| |
|
9.
|
Anticipation
by Use |
| |
|
10.
|
Use
Prior to the Date of Filing |
| |
|
11.
|
Sale
in Plant Variety Right |
| |
|
12.
|
Ground
to Attack Validity |
| |
|
13.
|
Lack
of Novelty Led to Revocation |
|
3.
|
OBVIOUSNESS
|
|
|
| |
|
14.
|
Application
of Statutory test |
| |
|
15.
|
Prima
Facie Test |
| |
|
16.
|
Confirmation
through Prior Art Patent |
| |
|
17.
|
Technical
Problem in State-of-the-art |
| |
|
18.
|
state-of-the-art
on the Priority Date |
| |
|
19.
|
Lead
to Revocation |
| |
|
20.
|
Lead
to Revocation (Pharmaceutical) |
| |
|
21.
|
Powers
of Patent Board |
| |
|
22.
|
Summary
Judgement |
|
4.
|
DISCLOSURE
|
|
|
| |
|
23.
|
Sufficiency
of Disclosure |
| |
|
24.
|
Clarity
in Claims |
| |
|
25.
|
Need
for Precise Claims |
| |
|
26.
|
Complete
& Adequate |
| |
|
27.
|
Pharmaceutical
Invention |
| |
|
28.
|
Filing
Date |
| |
|
29.
|
Necessary
and Appropriate Amendments |
| |
|
30.
|
Revocation
for Insufficiency |
|
5.
|
ASPECTS
RELATING GRANT |
|
|
| |
5.1
Priority |
31.
|
Priority
Rights |
| |
|
32.
|
Priority
Determination |
| |
|
33.
|
Reducing
Invention to Practice |
| |
|
|
|
| |
5.2
Inventor |
34.
|
Inventor
|
| |
|
35.
|
Inventor/Owner
|
| |
|
36.
|
Experimental
Exemption |
| |
|
37.
|
Sale
for Clinical Trials |
| |
|
38.
|
Experimental
Exemption Clinical Trials |
|
6.
|
SPECIAL
ISSUES |
|
|
| |
6.1
Board Patents |
39.
|
Board
Patents Though Amendments |
| |
|
40.
|
Genetic
Engineering |
| |
|
41.
|
Transgenic
Animals |
| |
|
|
|
| |
6.2
Doctrine of Equivalents |
|
|
| |
|
42.
|
Hypothetical
Claim Analysis |
| |
|
43.
|
Functional
Equivalence |
| |
|
44.
|
Derive
Different Meaning |
| |
|
45.
|
To
Deal with Element of Claim |
| |
|
46.
|
Validity
Novelty |
| |
|
47.
|
US
Supreme Court Decision |
| |
|
|
|
| |
6.3
Compulsory License |
|
|
| |
|
48.
|
Grant
Upheld |
| |
|
49.
|
Dismissal
with Costs |
| |
|
50.
|
Prohibition
under TRIPS |
| |
|
|
|
| |
6.4
Parallel Imports & Exhaustion |
|
|
| |
|
51.
|
Exhaustion
General Principle |
| |
|
52.
|
Implication
in Transition |
| |
|
53.
|
Infringement
Disallowed |
| |
|
54.
|
Implication
for Second or Subsequent Purchasers |
| |
|
|
|
| |
6.5
Supplementary Protection |
|
|
| |
|
55.
|
Supplementary
Protection Certificate Application |
| |
|
56.
|
Date
of authorization |
| |
|
57.
|
Limited
to Pharmaceutical Substance |
|
7.
|
JURISDICTION
AND ALLIED MATTERS |
|
|
| |
|
58.
|
Patent
Amendment |
| |
|
59.
|
Injunction
or Revocation |
| |
|
60.
|
Jurisdiction
Over a Company |
| |
|
61.
|
Assignment
of Patent in writing |
| |
|
62.
|
Site
of Injury for Patent Infringement |
| |
|
63.
|
Review
Under Clear Error Standard |
| |
|
64.
|
European/National
Patent |
| |
|
65.
|
Pan-European
Patent Litigation |
|
8.
|
INFRINGEMENT
|
|
|
| |
|
66.
|
Scope
of Protection |
| |
|
67.
|
Patents
Lapsed or Not |
| |
|
68.
|
Parties-Joinder/Non
Joinder |
| |
|
69.
|
Term
Interpretation |
| |
|
70.
|
Double
Patenting |
| |
|
71.
|
Equitable
Conduct |
| |
|
72.
|
Process
Patent |
| |
|
73.
|
Restriction
of Import during the Life of a Patent |
| |
|
74.
|
Multiple
Theories for Infringement |
| |
|
75.
|
Literal
Infringement & Equivalence |
| |
|
76.
|
Wilful
Confirmed |
| |
|
77.
|
Wilful
Confirmed |
| |
|
78.
|
Wilful
Reversed |
| |
|
79.
|
Declaratory
Judgement |
| |
|
80.
|
Laches
and Estoppel |
| |
|
81.
|
Claim
Construction |
|
9.
|
RELIEF
|
|
|
| |
9.1
Injunction |
82.
|
Ground
for Preliminary Injunction |
| |
|
83.
|
Novelty
Injunction denied |
| |
|
84.
|
Changes
in the Process |
| |
|
85.
|
Sale
of Product |
| |
|
86.
|
Injunctive
Relief Confirmed |
| |
|
87.
|
Injunctive
Relief Refused |
| |
9.2
Damages |
88.
|
Damages
Claim for a Parent Company |
| |
|
89.
|
Valuation
of Patent Compensation |
| |
|
90.
|
Challenge
to Validity Patent License |
|
10.
|
REVOCATION
|
|
|
| |
|
91.
|
Amendment
of the Patent |
| |
|
92.
|
Opportunity
for Amendment |
| |
|
93.
|
Wrongfully
Operated Patent |
| |
|
94.
|
Plurality
of Proofs |
| |
|
95.
|
Revocation
Declined |
| |
|
96.
|
Motion
for Contempt |
| |
|
97.
|
European
Patent |
|
11.
|
PROCEDURES
|
|
|
| |
|
98.
|
Divisional
Application EPC |
| |
|
99.
|
Fresh
Grounds for Opposition |
| |
|
100.
|
Legality
of Summoning of Documents |
| |
|
101.
|
Conflict
of Laws |
